1. Home
  2. HPP vs LAB Comparison

HPP vs LAB Comparison

Compare HPP & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Pacific Properties Inc.

HPP

Hudson Pacific Properties Inc.

HOLD

Current Price

$8.23

Market Cap

553.0M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$1.32

Market Cap

488.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HPP
LAB
Founded
1997
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
553.0M
488.4M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
HPP
LAB
Price
$8.23
$1.32
Analyst Decision
Hold
Hold
Analyst Count
12
2
Target Price
$17.27
$1.35
AVG Volume (30 Days)
1.2M
1.5M
Earning Date
02-26-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$781,676,000.00
$169,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.77
52 Week Low
$8.12
$0.92
52 Week High
$23.52
$1.72

Technical Indicators

Market Signals
Indicator
HPP
LAB
Relative Strength Index (RSI) 35.46 38.41
Support Level $8.62 $1.36
Resistance Level $9.00 $1.46
Average True Range (ATR) 0.41 0.09
MACD -0.19 -0.03
Stochastic Oscillator 5.29 4.06

Price Performance

Historical Comparison
HPP
LAB

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: